ARCHIVES

CMS Issues Coverage Decision For Provenge in Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

DRCCA Organization To Include Three Programs, With Centers In One

August 8, 1980

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

Fruit, Candy Flavored Cigarettes Banned In U.S.; FDA To Examine Menthol Flavored Tobacco

September 25, 2009

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

May 20, 2005

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994